[DISCLOSURE] Hanmi Pharmaceutical (128940) and its affiliate Hanmi Science (008930) have sold all of their shares of Crystal Genomics (083790), the companies announced on June 15. They owned 1.48 million shares of the drug developer or a 14.34 percent stake.